NRA-ALENDRONATE
Identification of Nra-Alendronate
| No description |
Google image searchProduct monograph
Active ingredient
alendronic acid (alendronate sodium), 70 MG
DIN: 02523116
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NORA PHARMA INC
Date: 09-AUG-2022
ATC:
- M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
- M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
- M05BA — Bisphosphonates (ATC, ATC/DDD)
- M05BA04 — ALENDRONIC ACID (ATC/DDD)
Reference brand drug: Fosamax
Pharmaceutical standard: MFR
